These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 19715972

  • 1. Risk factors in patients with rapid recurrent hepatitis C virus-related cirrhosis within 1 year after liver transplantation.
    Zimmermann T, Otto C, Hoppe-Lotichius M, Biesterfeld S, Lautem A, Knaak M, Zimmermann A, Barreiros AP, Heise M, Schattenberg JM, Sprinzl MF, Galle PR, Otto G, Schuchmann M.
    Transplant Proc; 2009; 41(6):2549-56. PubMed ID: 19715972
    [Abstract] [Full Text] [Related]

  • 2. Use of OKT3 is associated with early and severe recurrence of hepatitis C after liver transplantation.
    Rosen HR, Shackleton CR, Higa L, Gralnek IM, Farmer DA, McDiarmid SV, Holt C, Lewin KJ, Busuttil RW, Martin P.
    Am J Gastroenterol; 1997 Sep; 92(9):1453-7. PubMed ID: 9317061
    [Abstract] [Full Text] [Related]

  • 3. Predictors of survival after liver transplantation for hepatocellular carcinoma associated with Hepatitis C.
    Shimoda M, Ghobrial RM, Carmody IC, Anselmo DM, Farmer DG, Yersiz H, Chen P, Dawson S, Durazo F, Han S, Goldstein LI, Saab S, Hiatt J, Busuttil RW.
    Liver Transpl; 2004 Dec; 10(12):1478-86. PubMed ID: 15558585
    [Abstract] [Full Text] [Related]

  • 4. Recurrent hepatitis C virus infection after liver transplantation--long-term follow-up with respect to the HCV genotypes/subtypes.
    Arnold JC, Töx U, Goeser T, Otto G, Müller HM, Hofmann WJ, Stremmel W, Theilmann L.
    Z Gastroenterol; 1997 Apr; 35(4):255-61. PubMed ID: 9163889
    [Abstract] [Full Text] [Related]

  • 5. The influence of viral genotypes and rejection episodes on the recurrence of hepatitis C after liver transplantation.
    Sugo H, Balderson GA, Crawford DH, Fawcett J, Lynch SV, Strong RW, Futagawa S.
    Surg Today; 2003 Apr; 33(6):421-5. PubMed ID: 12768367
    [Abstract] [Full Text] [Related]

  • 6. Fibrosis progression after liver transplantation in patients with recurrent hepatitis C.
    Neumann UP, Berg T, Bahra M, Seehofer D, Langrehr JM, Neuhaus R, Radke C, Neuhaus P.
    J Hepatol; 2004 Nov; 41(5):830-6. PubMed ID: 15519657
    [Abstract] [Full Text] [Related]

  • 7. The significance of metabolic syndrome in the setting of recurrent hepatitis C after liver transplantation.
    Hanouneh IA, Feldstein AE, McCullough AJ, Miller C, Aucejo F, Yerian L, Lopez R, Zein NN.
    Liver Transpl; 2008 Sep; 14(9):1287-93. PubMed ID: 18756451
    [Abstract] [Full Text] [Related]

  • 8. Liver transplantation using donors older than 80 years: a single-center experience.
    Petridis I, Gruttadauria S, Nadalin S, Viganò J, di Francesco F, Pietrosi G, Fili' D, Montalbano M, D'Antoni A, Volpes R, Arcadipane A, Vizzini G, Gridelli B.
    Transplant Proc; 2008 Sep; 40(6):1976-8. PubMed ID: 18675105
    [Abstract] [Full Text] [Related]

  • 9. HCV histological recurrence and survival following liver transplantation in patients with and without hepatocellular carcinoma.
    De Martin E, Senzolo M, Boninsegna S, Guido M, Masier A, Germani G, Tomat S, Brolese A, Neri D, Cillo U, Gambato M, Russo FP, Farinati F, Burra P.
    Transplant Proc; 2008 Sep; 40(6):1974-5. PubMed ID: 18675104
    [Abstract] [Full Text] [Related]

  • 10. Monitoring peripheral blood CD4+ adenosine triphosphate activity in recurrent hepatitis C and its correlation to fibrosis progression.
    Alkhouri N, Hanouneh IA, Lopez R, Zein NN.
    Liver Transpl; 2010 Feb; 16(2):155-62. PubMed ID: 20104483
    [Abstract] [Full Text] [Related]

  • 11. Liver transplantation for hepatitis C: recurrence and disease progression in 300 patients.
    Testa G, Crippin JS, Netto GJ, Goldstein RM, Jennings LW, Brkic BS, Brooks BK, Levy MF, Gonwa TA, Klintmalm GB.
    Liver Transpl; 2000 Sep; 6(5):553-61. PubMed ID: 10980053
    [Abstract] [Full Text] [Related]

  • 12. Hepatocellular carcinoma: Can it be considered a controversial indication for liver transplantation in centers with high rates of hepatitis C?
    Moya A, Berenguer M, Aguilera V, Juan FS, Nicolás D, Pastor M, López-Andujar R, Rayón M, Orbis F, Mora J, De Juan M, Carrasco D, Vila JJ, Prieto M, Berenguer J, Mir J.
    Liver Transpl; 2002 Nov; 8(11):1020-7. PubMed ID: 12424715
    [Abstract] [Full Text] [Related]

  • 13. IgM anti-hepatitis C virus core antibodies as marker of recurrent hepatitis C after liver transplantation.
    Negro F, Giostra E, Rubbia-Brandt L, Mentha G, Colucci G, Morel P, Quadri R, Perrin L, Hadengue A.
    J Med Virol; 1998 Nov; 56(3):224-9. PubMed ID: 9783689
    [Abstract] [Full Text] [Related]

  • 14. Survival and hepatitis C virus recurrence after liver transplantation in HIV- and hepatitis C virus-coinfected patients: experience in a single center.
    Testillano M, Fernandez JR, Suarez MJ, Gastaca M, Bustamante J, Pijoan JI, Montejo M, Valdivieso A, Ruiz P, Gonzalez J, Ortiz de Urbina J.
    Transplant Proc; 2009 Apr; 41(3):1041-3. PubMed ID: 19376421
    [Abstract] [Full Text] [Related]

  • 15. Hepatocellular carcinoma in unrelated viral cirrhosis: long-term results after liver transplantation.
    Lauterio A, Di Sandro S, Slim A, Giacomoni A, Mangoni I, Mihaylov P, Pirotta V, Aseni P, De Carlis L.
    Transplant Proc; 2010 May; 42(4):1212-5. PubMed ID: 20534264
    [Abstract] [Full Text] [Related]

  • 16. Clinical outcomes of living donor liver transplantation for hepatitis C virus (HCV)-positive patients.
    Takada Y, Haga H, Ito T, Nabeshima M, Ogawa K, Kasahara M, Oike F, Ueda M, Egawa H, Tanaka K.
    Transplantation; 2006 Feb 15; 81(3):350-4. PubMed ID: 16477219
    [Abstract] [Full Text] [Related]

  • 17. Impact of donor graft steatosis on overall outcome and viral recurrence after liver transplantation for hepatitis C virus cirrhosis.
    Briceño J, Ciria R, Pleguezuelo M, de la Mata M, Muntané J, Naranjo A, Sánchez-Hidalgo J, Marchal T, Rufián S, López-Cillero P.
    Liver Transpl; 2009 Jan 15; 15(1):37-48. PubMed ID: 19109846
    [Abstract] [Full Text] [Related]

  • 18. The impact of nonalcoholic fatty liver disease and the metabolic syndrome on progression of fibrosis in patients with recurrent HCV after liver transplantation.
    Mindikoglu AL, Regev A, Casanova-Romero PY, Bejarano PA, Martinez EJ, Tzakis AG, Schiff ER.
    Transplant Proc; 2006 Jun 15; 38(5):1440-4. PubMed ID: 16797327
    [Abstract] [Full Text] [Related]

  • 19. One-year protocol liver biopsy can stratify fibrosis progression in liver transplant recipients with recurrent hepatitis C infection.
    Firpi RJ, Abdelmalek MF, Soldevila-Pico C, Cabrera R, Shuster JJ, Theriaque D, Reed AI, Hemming AW, Liu C, Crawford JM, Nelson DR.
    Liver Transpl; 2004 Oct 15; 10(10):1240-7. PubMed ID: 15376304
    [Abstract] [Full Text] [Related]

  • 20. Survival outcomes in liver transplantation for hepatocellular carcinoma, comparing impact of hepatitis C versus other etiology of cirrhosis.
    Bozorgzadeh A, Orloff M, Abt P, Tsoulfas G, Younan D, Kashyap R, Jain A, Mantry P, Maliakkal B, Khorana A, Schwartz S.
    Liver Transpl; 2007 Jun 15; 13(6):807-13. PubMed ID: 17539001
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.